Last checked at 22 Jul 2021 15:14
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | AON plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) | US$0.01 ordinary shares |
Date of dealing | 21 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities | 6,689,035 2.96 | 2,191,549 0.97 | ||||
(2) Derivatives (other than options) | 1,862,680 0.83 | 51,454 0.02 | ||||
(3) Options and agreements to purchase/sell | 126,500 0.06 | 368,300 0.16 | ||||
Total | 8,678,215 3.85 | 2,611,303 1.15 | ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
Sale(Barrow Return)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 7,400
143 13 118 82 19 114 575 33 8,650 100 288 244 295 294 4 100 203 1,137 131 101 685 92 268 53 3 36 78 127 84 208 100 100 1 200 142 201 33 136 37 100 88 102 355 246 43 37 716 37 100 842 137 200 600 1,422 500 59 162 2 424 10 152 52 120 93 100 204 303 100 180 160 345 1,750 56 114 100 64 240 53,847 17 7 188 1 7 18 15 1 1 6
143 9 53 7 26 34 27,832 6 203 4 150 11 124 1 36 34 1 13,816 250 1 136 1 200 1 77 162 4 85 100 123 115 52 2 2,961 8 11 200 1,300 22 1,750 11 598 5 7 10 3 4,100 202 1 849 45 193 53,847 22,712 2,392 11 17,550 1,827 2 2 19 111 18 12 2 120 1 200 2 27 | N/A
228.7900 USD 229.9650 USD 229.9790 USD 229.9850 USD 229.9900 USD 230.0200 USD 230.0278 USD 230.0400 USD 230.0600 USD 230.1300 USD 230.1400 USD 230.1605 USD 230.1900 USD 230.2838 USD 230.3000 USD 230.3300 USD 230.4886 USD 230.5710 USD 230.6600 USD 230.7000 USD 230.7332 USD 230.7400 USD 230.7500 USD 230.7600 USD 230.7800 USD 230.8247 USD 230.8374 USD 230.8400 USD 230.8500 USD 230.8921 USD 230.9100 USD 230.9300 USD 230.9800 USD 230.9900 USD 231.0000 USD 231.0086 USD 231.0100 USD 231.0198 USD 231.0200 USD 231.0500 USD 231.0700 USD 231.0800 USD 231.0900 USD 231.0904 USD 231.1080 USD 231.1200 USD 231.1227 USD 231.1300 USD 231.1400 USD 231.1456 USD 231.1500 USD 231.1800 USD 231.1832 USD 231.1850 USD 231.2010 USD 231.2100 USD 231.2105 USD 231.3100 USD 231.3220 USD 231.4000 USD 231.4100 USD 231.4135 USD 231.4300 USD 231.4340 USD 231.4900 USD 231.5000 USD 231.5051 USD 231.5300 USD 231.5600 USD 231.5900 USD 231.5904 USD 231.5910 USD 231.6100 USD 231.6300 USD 231.6400 USD 231.6810 USD 231.7000 USD 231.8418 USD 231.9480 USD 232.0100 USD 232.1185 USD 232.1200 USD 232.2100 USD 232.3900 USD 232.5200 USD 232.5800 USD 232.5900 USD 233.6750 USD
228.7900 USD 229.9000 USD 229.9042 USD 229.9050 USD 229.9600 USD 230.0312 USD 230.0600 USD 230.3833 USD 230.4886 USD 230.4900 USD 230.6951 USD 230.7300 USD 230.7400 USD 230.8100 USD 230.8247 USD 230.8250 USD 230.8300 USD 230.8700 USD 230.9620 USD 231.0100 USD 231.0198 USD 231.0200 USD 231.0900 USD 231.1700 USD 231.2100 USD 231.2105 USD 231.2200 USD 231.2808 USD 231.3300 USD 231.3377 USD 231.3674 USD 231.4135 USD 231.4200 USD 231.4446 USD 231.4900 USD 231.5200 USD 231.5350 USD 231.5515 USD 231.5550 USD 231.5910 USD 231.6300 USD 231.6445 USD 231.6620 USD 231.6971 USD 231.7180 USD 231.7200 USD 231.7375 USD 231.7400 USD 231.7500 USD 231.8083 USD 231.8182 USD 231.8245 USD 231.8418 USD 231.8755 USD 231.9018 USD 231.9168 USD 231.9216 USD 231.9835 USD 232.0200 USD 232.0400 USD 232.1600 USD 232.2200 USD 232.2789 USD 232.2875 USD 232.3200 USD 232.4538 USD 232.5900 USD 232.6950 USD 232.7900 USD 232.8270 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
|
Equity Swap | Decrease Long
Decrease Short
Increase Long | 52
203 12,274 41,573
1,750 | 231.4135 USD
230.4886 USD 231.6343 USD 231.9030 USD
231.5970 USD |
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price (USD) | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) (USD) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
Date of disclosure | 22 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, e.g. call option | Written, or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) (USD) | Type, e.g. American, European etc. | Expiry date |
Call Option Call Option Call Option Call Option Call Option Call Option Call Option Call Option Put Option Put Option Put Option | Written Written Written Written Purchased Purchased Purchased Written Written Written Written | 46,200 71,700 77,400 104,700 300 54,200 72,000 3,100 44,000 600 20,600 | 270.00 270.00 270.00 270.00 240.00 260.00 260.00 270.00 230.00 240.00 250.00 | American American American American American American American American American American American | 17/12/2021 17/12/2021 17/12/2021 17/12/2021 15/10/2021 15/10/2021 17/12/2021 17/12/2021 15/10/2021 15/10/2021 17/12/2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.